Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03945279
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 49
Testing effectiveness (Phase 2)Study completedNCT00107770
What this trial is testing

Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)

Who this might be right for
Amyotrophic Lateral Sclerosis
US Department of Veterans Affairs 40
Large-scale testing (Phase 3)Looking for participantsNCT07322003
What this trial is testing

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Prilenia 500
Not applicableStudy completedNCT04798183
What this trial is testing

Geometrical Facial Deformation According to Posture in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Pusan National University Yangsan Hospital 28
Testing effectiveness (Phase 2)Study completedNCT02059759
What this trial is testing

Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2

Who this might be right for
Amyotrophic Lateral Sclerosis
Centre Hospitalier Universitaire de Nīmes 36
Not applicableNot Yet RecruitingNCT07698496
What this trial is testing

Evaluation of the Feasibility and Efficacy of a Chronic Brain-computer Interface for Speech Rehabilitation in Patients With Locked-in-syndrome (LIS)

Who this might be right for
Locked in SyndromeALS (Amyotrophic Lateral Sclerosis)
University Hospital, Grenoble 3
Not applicableStudy completedNCT00961103
What this trial is testing

Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)

Who this might be right for
Spinal Muscular Atrophy
Azienda USL Reggio Emilia - IRCCS 80
Not applicableTemporarily pausedNCT01959373
What this trial is testing

Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique Hopitaux De Marseille 30
Not applicableStudy completedNCT02405182
What this trial is testing

MRI Biomarkers in ALS

Who this might be right for
Amyotrophic Lateral SclerosisALSMotor Neuron Diseases
University of Alberta 145
Not applicableLooking for participantsNCT06318585
What this trial is testing

Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
Istituto Auxologico Italiano 200
Large-scale testing (Phase 3)Active Not RecruitingNCT04042025
What this trial is testing

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

Who this might be right for
Spinal Muscular Atrophy Type ISpinal Muscular Atrophy Type IISpinal Muscular Atrophy Type III+1 more
Novartis Gene Therapies 85
Testing effectiveness (Phase 2)Study completedNCT01281631
What this trial is testing

NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuraltus Pharmaceuticals, Inc. 136
Not applicableNo Longer AvailableNCT03537807
What this trial is testing

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT02633709
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) Given by Mouth in Healthy Volunteers

Who this might be right for
Spinal Muscular Atrophy
Hoffmann-La Roche 33
Not applicableActive Not RecruitingNCT04875416
What this trial is testing

Phenotype, Genotype and Biomarkers 2

Who this might be right for
Amyotrophic Lateral SclerosisHereditary Spastic ParaplegiaPrimary Lateral Sclerosis+2 more
University of Miami 217
Not applicableStudy completedNCT05404867
What this trial is testing

Study of Structural and Functional Brain Connectivity Changes in ALS (CoALS-II)

Who this might be right for
Amyotrophic Lateral Sclerosis
Dartmouth-Hitchcock Medical Center 31
Not applicableLooking for participantsNCT06147843
What this trial is testing

French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Limoges 1,000
Not applicableLooking for participantsNCT06553976
What this trial is testing

Spastic Paraplegia - Centers of Excellence Research Network

Who this might be right for
Hereditary Spastic ParaplegiaPrimary Lateral SclerosisSPG4+6 more
Boston Children's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00214110
What this trial is testing

Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
University of Wisconsin, Madison 100
Testing effectiveness (Phase 2)Study completedNCT04470050
What this trial is testing

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Who this might be right for
Opioid Withdrawal
BioXcel Therapeutics Inc 225
Next Page